{"id":"azp2006-oral-solution","_chembl":null,"modality":"Small molecule","_dailymed":null,"_scrapedAt":"2026-03-28T02:30:34.384Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123724,"model":"claude-sonnet-4-5-20250929"},"description":"AZP2006 is an oral solution in Phase 2 clinical development by AlzProtect SAS. The drug is being investigated for potential therapeutic applications, though specific molecular targets and indications have not been publicly disclosed at this time.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT04008355","phase":"PHASE2","title":"A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP","status":"COMPLETED","sponsor":"AlzProtect SAS","startDate":"2020-06-22","conditions":"Progressive Supranuclear Palsy","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AZP2006 oral solution","genericName":"AZP2006 oral solution","companyName":"AlzProtect SAS","companyId":"alzprotect-sas","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}